26 Nov 2021 by admin in UncategorizedComments Crescendo Biologics Wins “Best Established Biotech Company” at the 2021 OBN Awards
21 Nov 2021 by admin in UncategorizedComments Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
18 Nov 2021 by admin in UncategorizedComments Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
18 Nov 2021 by admin in UncategorizedComments Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
18 Nov 2021 by admin in UncategorizedComments Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors
16 Nov 2021 by admin in UncategorizedComments KIRA PHARMACEUTICALS APPOINTS TERI LOXAM AS CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER
12 Nov 2021 by admin in UncategorizedComments Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
10 Nov 2021 by admin in UncategorizedComments Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
10 Nov 2021 by admin in UncategorizedComments Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
09 Nov 2021 by admin in UncategorizedComments Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
